The oncogenic role of TTPAL is proved in ESCC progression, providing new insights into the regulation of cholesterol biosynthesis signaling in ESCC and establishing TTPAL as a biomarker for simvastatin therapy resistance in ESCC. The gene discussed is TTPAL; the disease is esophageal squamous cell carcinoma.